Targeting the Activator Protein 1 Transcription Factor for the Prevention of Estrogen Receptor-Negative Mammary Tumors

The oncogene erbB2 is overexpressed in 20% to 30% human breast cancers and is most commonly overexpressed in estrogen receptor (ER)-negative breast cancers. Transgenic mice expressing erbB2 develop ER-negative mammary tumors, mimicking human breast carcinogenesis. Previously, we have shown that acti...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Shen, Qiang, Uray, Ivan P., Li, Yuxin, Zhang, Yun, Hill, Jamal, Xu, Xiao-Chun, Young, Matthew R., Gunther, Edward J., Hilsenbeck, Susan G., Colburn, Nancy H., Chodosh, Lewis A., Brown, Powel H.
Format: Artigo
Langue:Inglês
Publié: 2008
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2577387/
https://ncbi.nlm.nih.gov/pubmed/19138935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-08-0034
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires